Who are Atrandi Biosciences's investors?

Atrandi Biosciences's investors include GRIDS Capital, Lux Capital, Metaplanet, Practica Capital, Vsquared Ventures.

How much funding has Atrandi Biosciences raised?

Atrandi Biosciences has disclosed $25M raised across 1 round.

Where is Atrandi Biosciences headquartered?

Atrandi Biosciences is headquartered in Vilnius, LT.

Atrandi Biosciences

Vilnius, LT · Founded 2016 · 79 employees on LinkedIn · 6 known investors

Find your way into Atrandi Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Atrandi Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Atrandi makes Flux, a device that isolates thousands to hundreds of thousands of individual cells simultaneously into semi-permeable capsules for downstream genomic and microbial analysis. The system is designed for life science research and can operate in field settings or laboratory environments.

AI & Machine Learning Biotech Deep Tech Hardware

Investors · 6

GRIDS Capital✓ confirmed by Atrandi BiosciencesSão Paulo

How we know: the company's own site · funding news · genomeweb.com · Not right? Tell us

Lux Capital✓ confirmed by Atrandi BiosciencesNew York · $100K – $100M

How we know: Lux Capital's portfolio page · the company's own site · funding news · genomeweb.com · Not right? Tell us

Metaplanet✓ confirmed by Atrandi BiosciencesTallinn · $500K – $10M

How we know: the company's own site · Metaplanet's portfolio page · funding news · genomeweb.com · the VCSheet dataset · Not right? Tell us

Practica Capital✓ confirmed by Atrandi BiosciencesVilnius · $324K – $3.2M

How we know: the company's own site · funding news · genomeweb.com · the VCSheet dataset · Not right? Tell us

Vsquared Ventureslisted by Vsquared VenturesMünchen

How we know: Vsquared Ventures's portfolio page · a partner's Signal profile · funding news · genomeweb.com · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 1

CRIDS Capital

Funding

SEC filings, press & company announcements

$25M disclosed across 1 round · 2025

$25MSeries AFeb 2025 · 3 sources
Lux Capital (lead), CRIDS Capital, GRIDS Capital, Metaplanet, Practica Capital, Vsquared Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technologyglobenewswire.com · Feb 2025

Frequently asked questions

What does Atrandi Biosciences do?: Atrandi makes Flux, a device that isolates thousands to hundreds of thousands of individual cells simultaneously into semi-permeable capsules for downstream genomic and microbial analysis. The system is designed for life science research and can operate in field settings or laboratory environments.
Who are Atrandi Biosciences's investors?: Atrandi Biosciences's investors include GRIDS Capital, Lux Capital, Metaplanet, Practica Capital, Vsquared Ventures.
How much funding has Atrandi Biosciences raised?: Atrandi Biosciences has disclosed $25M raised across 1 round.
Where is Atrandi Biosciences headquartered?: Atrandi Biosciences is headquartered in Vilnius, LT.